Oct 24 (Reuters) – Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumors to disappear or shrink in an early-stage trial. J&J had gained access to the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
KYIV, Oct 24 (Reuters) - The Starlink satellite communications system and its military version Starshield…
Oct 24 (Reuters) - An earthquake of magnitude 5.3 struck China's Tibet on Saturday, the…
KYIV, Oct 24 (Reuters) - The Starlink satellite communications system and its military version Starshield…
VIDEO SHOWS: HIGHLIGHTS OF THE AUSTRALIA MOTOGP QUALIFYING AND SPRINT RACE RESENDING WITH COMPLETE SHOTLIST…
Quepem (Goa) [India], October 24: In October 2026 Physiotherapy and Rehabilitation Centers were inaugurated in…
SAUDI LED COALITION SAYS IT INTERCEPTED AND DESTROYED TWO BALLISTIC MISSILES LAUNCHED BY YEMEN'S HOUTHIS…